# Economic and Financial Impacts of Cancer

**Type:** Topics  
**Canonical URL:** https://scholariq.org/topics/economic-and-financial-impacts-of-cancer/

## Facts

| Field | Value |
| --- | --- |
| Description | This cluster of papers focuses on the economic burden and financial impact of cancer treatment, including the concept of financial toxicity, out-of-pocket costs, healthcare expenditure, cost communication, and drug pricing. It addresses the challenges related to the cost of care, financial hardship experienced by patients, and the implications for both patients and healthcare systems. |
| Domain | Social Sciences |
| Field | Economics, Econometrics and Finance |
| OpenAlex ID | t12708 |
| Works | 256 |

## Topic papers all

Showing 15 of 256.

- [The Functional Assessment of Cancer Therapy scale: development and validation of the general measure.](https://scholariq.org/papers/the-functional-assessment-of-cancer-therapy-scale-development-and-validation-of/)
- [Cancer treatment and survivorship statistics, 2019](https://scholariq.org/papers/cancer-treatment-and-survivorship-statistics-2019/)
- [Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses](https://scholariq.org/papers/recommendations-for-conduct-methodological-practices-and-reporting-of-cost/)
- [Consolidated Health Economic Evaluation Reporting Standards (CHEERS)—Explanation and Elaboration: A Report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force](https://scholariq.org/papers/consolidated-health-economic-evaluation-reporting-standards-cheers-explanation/)
- [Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019](https://scholariq.org/papers/cancer-incidence-mortality-years-of-life-lost-years-lived-with-disability-and/)
- [Reliability and validity of the Functional Assessment of Cancer Therapy-Breast quality-of-life instrument.](https://scholariq.org/papers/reliability-and-validity-of-the-functional-assessment-of-cancer-therapy-breast/)
- [Future of Cancer Incidence in the United States: Burdens Upon an Aging, Changing Nation](https://scholariq.org/papers/future-of-cancer-incidence-in-the-united-states-burdens-upon-an-aging-changing/)
- [Changing cancer survival in China during 2003–15: a pooled analysis of 17 population-based cancer registries](https://scholariq.org/papers/changing-cancer-survival-in-china-during-2003-15-a-pooled-analysis-of-17/)
- [Improved Survival in Metastatic Colorectal Cancer Is Associated With Adoption of Hepatic Resection and Improved Chemotherapy](https://scholariq.org/papers/improved-survival-in-metastatic-colorectal-cancer-is-associated-with-adoption-of/)
- [US Health Care Spending by Payer and Health Condition, 1996-2016](https://scholariq.org/papers/us-health-care-spending-by-payer-and-health-condition-1996-2016/)
- [Anticipating the “Silver Tsunami”: Prevalence Trajectories and Co-Morbidity Burden among Older Cancer Survivors in the United States](https://scholariq.org/papers/anticipating-the-silver-tsunami-prevalence-trajectories-and-co-morbidity-burden/)
- [Annual report to the nation on the status of cancer, 1975–2001, with a special feature regarding survival](https://scholariq.org/papers/annual-report-to-the-nation-on-the-status-of-cancer-1975-2001-with-a-special/)
- [Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995–2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data](https://scholariq.org/papers/cancer-survival-in-australia-canada-denmark-norway-sweden-and-the-uk-1995-2007/)
- [Delivering High-Quality Cancer Care: Charting a New Course for a System in Crisis](https://scholariq.org/papers/delivering-high-quality-cancer-care-charting-a-new-course-for-a-system-in-crisis/)
- [Estimation of minimally important differences in EQ-5D utility and VAS scores in cancer](https://scholariq.org/papers/estimation-of-minimally-important-differences-in-eq-5d-utility-and-vas-scores-in/)

## Topic primary papers

Showing 15 of 57.

- [Delivering High-Quality Cancer Care: Charting a New Course for a System in Crisis](https://scholariq.org/papers/delivering-high-quality-cancer-care-charting-a-new-course-for-a-system-in-crisis/)
- [American Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment Options](https://scholariq.org/papers/american-society-of-clinical-oncology-statement-a-conceptual-framework-to-assess/)
- [Estimates and Projections of the Global Economic Cost of 29 Cancers in 204 Countries and Territories From 2020 to 2050](https://scholariq.org/papers/estimates-and-projections-of-the-global-economic-cost-of-29-cancers-in-204/)
- [Delivering affordable cancer care in high-income countries](https://scholariq.org/papers/delivering-affordable-cancer-care-in-high-income-countries/)
- [Financial Hardship Associated With Cancer in the United States: Findings From a Population-Based Sample of Adult Cancer Survivors](https://scholariq.org/papers/financial-hardship-associated-with-cancer-in-the-united-states-findings-from-a/)
- [Financial Burdens of Cancer Treatment: A Systematic Review of Risk Factors and Outcomes](https://scholariq.org/papers/financial-burdens-of-cancer-treatment-a-systematic-review-of-risk-factors-and/)
- [Are survivors who report cancer‐related financial problems more likely to forgo or delay medical care?](https://scholariq.org/papers/are-survivors-who-report-cancer-related-financial-problems-more-likely-to-forgo/)
- [Missed Opportunities: Racial Disparities in Adjuvant Breast Cancer Treatment](https://scholariq.org/papers/missed-opportunities-racial-disparities-in-adjuvant-breast-cancer-treatment/)
- [For Working-Age Cancer Survivors, Medical Debt And Bankruptcy Create Financial Hardships](https://scholariq.org/papers/for-working-age-cancer-survivors-medical-debt-and-bankruptcy-create-financial/)
- [Health Care Costs for Patients With Cancer at the End of Life](https://scholariq.org/papers/health-care-costs-for-patients-with-cancer-at-the-end-of-life/)
- [Death or Debt? National Estimates of Financial Toxicity in Persons with Newly-Diagnosed Cancer](https://scholariq.org/papers/death-or-debt-national-estimates-of-financial-toxicity-in-persons-with-newly/)
- [Assessment of costs associated with adverse events in patients with cancer](https://scholariq.org/papers/assessment-of-costs-associated-with-adverse-events-in-patients-with-cancer/)
- [Financial Burden of Pediatric Cancer for Patients and Their Families](https://scholariq.org/papers/financial-burden-of-pediatric-cancer-for-patients-and-their-families/)
- [Financial toxicity of cancer care in low- and middle-income countries: a systematic review and meta-analysis](https://scholariq.org/papers/financial-toxicity-of-cancer-care-in-low-and-middle-income-countries-a-2/)
- [Understanding financial toxicity in head and neck cancer survivors](https://scholariq.org/papers/understanding-financial-toxicity-in-head-and-neck-cancer-survivors/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.